-
Hoch, E., Murawski, M., Ferri, M. et al. Cannabis use disorder: an overview of treatment approaches in Europe. Eur Arch Psychiatry Clin Neurosci (2025).
-
Hoch, E., Hall, W. & Feingold, D. Cannabis use in Europe. Eur Arch Psychiatry Clin Neurosci (2025).
-
Stampf, A., Schwarzkopf, L., Batalla, A. et al. Cannabis-related treatment demand at the eve of German cannabis legalization – a 20-years trend analysis. Eur Arch Psychiatry Clin Neurosci (2024).
-
Feingold, D., Tzur Bitan, D., Ferri, M. et al. Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature. Eur Arch Psychiatry Clin Neurosci (2024).
-
Daniel Feingold, Yuval Neria, Dana Tzur Bitan, PTSD, distress and substance use in the aftermath of October 7th, 2023, terror attacks in Southern Israel, Journal of Psychiatric Research, Volume 174, 2024, Pages 153-158
-
Daniel Feingold, Or Gliksberg, Silviu Brill, Ben H. Amit, Shaul Lev-Ran, Talma Kushnir, Sharon R. Sznitman,
Conceptualizing problematic use of medicinal Cannabis: Development and preliminary validation of a brief screening questionnaire, Addictive Behaviors, Volume 158, 2024, 108122
-
Ashwal-Malka, A., Braw, Y. & Feingold, D. Cannabis Use and Emotions in Romantic Relationships. Curr Addict Rep 11, 654–662 (2024).
-
: Omer Sedoff, Daniel Feingold & Dana Tzur Bitan (18 Dec 2024): Social Support as Resilience Factor in the Aftermath of October 7th Attack, Journal of Loss and Trauma
-
Alcaraz-Silva, J., Feingold, D., Viana-Torre, G., Budde, H., Imperatori, C., Machado, S., & Murillo-Rodríguez, E. (2023). The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 22(3), 417-430.
-
Hulaihel, A., Gliksberg, O., Feingold, D., Brill, S., Amit, B. H., Lev‐ran, S., & Sznitman, S. R. (2023). Medical cannabis and stigma: a qualitative study with patients living with chronic pain. Journal of Clinical Nursing, 32(7-8), 1103-1114.
-
Gliksberg, O., Kushnir, T., Sznitman, S. R., Lev‐Ran, S., Brill, S., Amit, B. H., & Feingold, D. (2023). Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies. Journal of Clinical Nursing.
-
Feingold, D., & Gliksberg, O. (2023). Defining problematic use of medicinal cannabis: Theoretical and empirical considerations. In Medicinal Usage of Cannabis and Cannabinoids (pp. 105-116). Academic Press.
-
de Carvalho, J., Lerner, A., & Feingold, D. (2022). Management of Hyperhomocysteinemia, Low Vitamin Levels, and Low Cortisol in Cannabis Users: A Report of 2 Cases. Journal of Chiropractic Medicine, 21(4), 322-326.
-
Gliksberg, O., Livne, O., Lev-Ran, S., Rehm, J., Hasson-Ohayon, I., & Feingold, D. (2022). The association between cannabis use and perceived social support: The mediating role of decreased social network. International Journal of Mental Health and Addiction, 20(5), 2799-2812.
-
Feingold, D., & Tzur Bitan, D. (2022). Addiction psychotherapy: Going beyond self-medication. Frontiers in Psychiatry, 13, 820660.
-
Asper, A., Binenfeld, E., Pshitizky, H., & Feingold, D. (2022). Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans. Journal of Substance Abuse Treatment, 139, 108786.
-
Ashwal-Malka, A., Tal-Kishner, K., & Feingold, D. (2022). Moral injury and cannabis use disorder among Israeli combat veterans: The role of depression and perceived social support. Addictive behaviors, 124, 107114.
-
Feingold, D., & Zerach, G. (2021). Emotion regulation and experiential avoidance moderate the association between posttraumatic symptoms and alcohol use disorder among Israeli combat veterans. Addictive Behaviors, 115, 106776.
-
Tzur Bitan, D., Krieger, I., Kridin, K., Komantscher, D., Scheinman, Y., Weinstein, O., ... & Feingold, D. (2021). COVID-19 prevalence and mortality among schizophrenia patients: a large-scale retrospective cohort study. Schizophrenia Bulletin, 47(5), 1211-1217.
-
Serebro, M., Sobol-Goldberg, S., & Feingold, D. (2021). From Enchantment to Disillusion: A Narrative Exploration of Cannabis Use Disorder Among Young Israeli Combat Veterans. Frontiers in Psychiatry, 12, 643618.
-
López-Pelayo, H., Matrai, S., Balcells-Olivero, M., Campeny, E., Braddick, F., Bossong, M. G., ... & Gual, A. (2021). Supporting future cannabis policy–developing a standard joint unit: A brief back-casting exercise. Frontiers in psychiatry, 12, 675033.
-
López-Pelayo, H., Matrai, S., Balcells-Olivero, M., Campeny, E., Braddick, F., Bossong, M. G., ... & Gual, A. (2021). Standard units for cannabis dose: Why is it important to standardize cannabis dose for drug policy and how can we enhance its place on the public health agenda?. International Journal of Drug Policy, 97.
-
Livne, O., Wengrower, T., Feingold, D., Shmulewitz, D., Hasin, D. S., & Lev-Ran, S. (2021). Religiosity and substance use in US adults: Findings from a large-scale national survey. Drug and alcohol dependence, 225, 108796.
-
Feingold, D., Hoch, E., Weinstein, A., & Hall, W. (2021). Psychological aspects of cannabis use and cannabis use disorder. Frontiers in Psychiatry, 12, 789197.
-
Feingold, D., & Zerach, G. (2021). Parental Reflectiveness, Posttraumatic Symptoms and Alcohol Use Disorder among Israeli Combat-Veteran Fathers. Journal of Child and Family Studies, 30(9), 2155-2164.
-
Feingold, D., & Weinstein, A. (2021). Cannabis and depression. Cannabinoids and Neuropsychiatric Disorders, 67-80.
